Edwards Lifesciences Corporation
EW
|
|
| |
|
| Trading Volume | 129,269 |
|
|
95.56 - 60.67 |
| Market Cap Full | $ 42.5B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -0.3% | 25.3% | 10.9% | -9.8% |
| Q2 | - | -1% | 14.1% | -19.2% |
| Q3 | - | 11.7% | -26.6% | -13.1% |
| Q4 | - | 11.9% | 10.2% | -9.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 2.8 | 8.1 | 12.7 | -10.1 | 1.2 | 7.3 | -32.7 | 11.7 | - | - | - | 3.9 |
| 2023 | |||||||||||
| 2.8 | 4.8 | 2.8 | 6.4 | -4.2 | 12 | -13 | -6.8 | -9.4 | -8 | 6.3 | 12.6 |
| 2022 | |||||||||||
| -16.4 | 2.9 | 4.8 | -10.1 | -4.4 | -5.9 | 5.7 | -10.4 | -8.3 | -12.3 | 6.7 | -3.4 |
| 2021 | |||||||||||
| -8.8 | 1.5 | -0.2 | 14.2 | 0.4 | 8 | 8.5 | 4.3 | -3.4 | 5.8 | -10.4 | 21.7 |
| 2020 | |||||||||||
| -0.1 | -12.7 | -7.1 | 15.3 | 3.3 | -69.3 | 13.5 | 9.5 | -7 | -10.2 | 17 | 7.9 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0.6 | 0.6 | 0.5 | 0.5 |
| Q2 | 0.5 | 0.7 | 0.8 | -0.2 |
| Q3 | 0.6 | 0.6 | 0.5 | 0.5 |
| Q4 | 0 | 0.7 | 0.5 | 0.5 |
| A | 1.69 | 2.4 | 2.4 | 1.3 |